A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.

Nehul S, Nagaraj SK, Narayan R, Singh A, Bhutkar M, Singh V, Rani R, Kaur H, Sharma AK, Kumar P, Sharma GK, Tripathi S, Tomar S

Open source

DOI
10.1007/s00705-026-06557-w
Published
2026 Feb 25
Container
Archives of virology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00705-026-06557-w,
  title = {A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.},
  author = {Nehul S and Nagaraj SK and Narayan R and Singh A and Bhutkar M and Singh V and Rani R and Kaur H and Sharma AK and Kumar P and Sharma GK and Tripathi S and Tomar S},
  year = {2026},
  journal = {Archives of virology},
  doi = {10.1007/s00705-026-06557-w},
  url = {https://doi.org/10.1007/s00705-026-06557-w}
}

RIS

TY  - JOUR
TI  - A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.
AU  - Nehul S
AU  - Nagaraj SK
AU  - Narayan R
AU  - Singh A
AU  - Bhutkar M
AU  - Singh V
AU  - Rani R
AU  - Kaur H
AU  - Sharma AK
AU  - Kumar P
AU  - Sharma GK
AU  - Tripathi S
AU  - Tomar S
PY  - 2026
JO  - Archives of virology
DO  - 10.1007/s00705-026-06557-w
UR  - https://doi.org/10.1007/s00705-026-06557-w
ER  - 

APA

S, N., SK, N., R, N., A, S., M, B., V, S., R, R., H, K., AK, S., P, K., GK, S., S, T., & S, T. (2026). A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.. Archives of virology. https://doi.org/10.1007/s00705-026-06557-w

Source records